Skip to main content

Table 1 Demographic information, laboratory information prior to the surgery and surgery duration in the AKI and non AKI groups

From: Urine neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute canine kidney injury

Parameter

AKI

No AKI

P a

Age (years)

3.7 ± 0.8, n = 12

4.1 ± 0.7, n = 26

0.749

Bodyweight (kg)

10.0 ± 2.0, n = 12

14 ± 2.4, n = 27

0.173

Admission BUN (mmol/L)

6.0 ± 0.85, n = 12

6.28 ± 0.43, n = 27

0.76

Surgery duration (h)

3.0 ± 0.8, n = 12

1.4 ± 0.1, n = 26

0.05

Admission Creatinine (μmol/L)

88.4 (53.0), n = 12

88.4 (26.5), n = 27

0.208

Gender (female)

58.3% (7/12)

70.4% (19/27)

0.486

Nephrotoxic drugs used b

50.0% (6/12)

40.7% (11/27)

0.590

  1. Continuous data agreeing with a normal distribution are presented as means ± S.E.M., otherwise, the median (IQR) are presented; categorical data are reported as a percentage.
  2. ap < 0.05 indicates a significant difference.
  3. bNephrotoxic drugs used include NSAIDs, aminoglycoside antibiotics, ACE-inhibitors and chemotherapeutic medicine such as carboplatin.